Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 2.9B | 3.0B | 2.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.0B | 954M | 958M | 909M |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.2B | 1.3B | 1.1B |
Tax provision | 286M | 235M | 273M | 234M |
Net income | 997M | 955M | 1.0B | 906M |
Basic EPS | 2.8 | — | 2.9 | 2.6 |
Diluted EPS | 2.8 | — | 2.9 | 2.5 |
Basic average shares | 533.4M | — | 532.6M | 531.6M |
Diluted average shares | 540.0M | — | 537.8M | 536.6M |
EBITDA | — | — | — | — |
Net income from continuing op. | 997M | 955M | 1.0B | 906M |
Minority interests | 0 | 0 | 0 | 1M |
Preferred stock dividends | — | — | — | — |